Discriminatory Power of Combinatorial Antigen Recognition in Cancer T Cell Therapies.
Discriminatory Power of Combinatorial Antigen Recognition in Cancer T Cell Therapies.
复制标题
DOI:
10.1016/j.cels.2020.08.002
复制
发表时间:
2020-09-23
期刊:
影响因子:
9.3
通讯作者:
Lim WA
中科院分区:
文献类型:
--
作者:
Dannenfelser R;Allen GM;VanderSluis B;Koegel AK;Levinson S;Stark SR;Yao V;Tadych A;Troyanskaya OG;Lim WA
Precise discrimination of tumor from normal tissues remains a major roadblock for therapeutic efficacy of chimeric antigen receptor (CAR) T cells. Here, we perform a comprehensive in silico screen to identify multi-antigen signatures that improve tumor discrimination by CAR T cells engineered to integrate multiple antigen inputs via Boolean logic, e.g., AND and NOT. We screen >2.5 million dual antigens and ~60 million triple antigens across 33 tumor types and 34 normal tissues. We find that dual antigens significantly outperform the best single clinically investigated CAR targets and confirm key predictions experimentally. Further, we identify antigen triplets that are predicted to show close to ideal tumor-versus-normal tissue discrimination for several tumor types. This work demonstrates the potential of 2- to 3-antigen Boolean logic gates for improving tumor discrimination by CAR T cell therapies. Our predictions are available on an interactive web server resource (antigen.princeton.edu). The application of CAR T cells to solid tumors is limited by the difficulty in identifying single target antigens that adequately discriminate between tumor and normal tissue to avoid toxicity. We leverage large-scale RNA-seq databases from tumor and normal tissues to evaluate the discriminatory power of single antigens and antigen combinations. Most single antigens, including those currently under investigation as CAR targets in solid tumors, perform poorly. The addition of a second or third antigen using AND or NOT gating can significantly improve CAR T cell performance. We construct and test a pair of potential AND-gated T cells for renal cell carcinoma. A full database of all predicted high-performing antigen pairs and triplets is made available in an associated web server (antigen.princeton.edu).
登录
查看更多内容
影响因子:
64.8
作者:
GTEx Consortium;Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group;Statistical Methods groups—Analysis Working Group;Enhancing GTEx (eGTEx) groups;NIH Common Fund;NIH/NCI;NIH/NHGRI;NIH/NIMH;NIH/NIDA;Biospecimen Collection Source Site—NDRI;Biospecimen Collection Source Site—RPCI;Biospecimen Core Resource—VARI;Brain Bank Repository—University of Miami Brain Endowment Bank;Leidos Biomedical—Project Management;ELSI Study;Genome Browser Data Integration &Visualization—EBI;Genome Browser Data Integration &Visualization—UCSC Genomics Institute, University of California Santa Cruz;Lead analysts:;Laboratory, Data Analysis &Coordinating Center (LDACC):;NIH program management:;Biospecimen collection:;Pathology:;eQTL manuscript working group:;Battle A;Brown CD;Engelhardt BE;Montgomery SB
通讯作者:
Montgomery SB
影响因子:
17.1
作者:
Fedorov VD;Themeli M;Sadelain M
通讯作者:
Sadelain M
DOI:
10.1007/s00262-017-2034-7
发表时间:
2017-11
期刊:
Cancer immunology, immunotherapy : CII
影响因子:
--
作者:
Thistlethwaite FC;Gilham DE;Guest RD;Rothwell DG;Pillai M;Burt DJ;Byatte AJ;Kirillova N;Valle JW;Sharma SK;Chester KA;Westwood NB;Halford SER;Nabarro S;Wan S;Austin E;Hawkins RE
通讯作者:
Hawkins RE
DOI:
10.1056/nejmoa1707447
发表时间:
2017-12-28
期刊:
The New England journal of medicine
影响因子:
--
作者:
Neelapu SS;Locke FL;Bartlett NL;Lekakis LJ;Miklos DB;Jacobson CA;Braunschweig I;Oluwole OO;Siddiqi T;Lin Y;Timmerman JM;Stiff PJ;Friedberg JW;Flinn IW;Goy A;Hill BT;Smith MR;Deol A;Farooq U;McSweeney P;Munoz J;Avivi I;Castro JE;Westin JR;Chavez JC;Ghobadi A;Komanduri KV;Levy R;Jacobsen ED;Witzig TE;Reagan P;Bot A;Rossi J;Navale L;Jiang Y;Aycock J;Elias M;Chang D;Wiezorek J;Go WY
通讯作者:
Go WY
影响因子:
2.9
作者:
Qu, Xiaohan;Liu, Jinlu;Zhang, Qigang
通讯作者:
Zhang, Qigang